Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Nitrite in PH-HFpEF
NCT03015402Phase 2Completed
- Sponsor
- University of Pittsburgh
- Start
- Oct 2017
- Primary completion
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sodium nitrite in pulmonary hypertension (PH), heart failure with preserved ejection fraction (HFpEF), sponsored by University of Pittsburgh. Started Oct 2017; status: completed.
02
Drugs
sodium nitrite
03
Conditions
pulmonary hypertension (PH)heart failure with preserved ejection fraction (HFpEF)
Beyond the preview
Go deeper on NCT03015402.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03015402.